1. Introduction {#sec1}
===============

The *CDKN2A* gene-product p16^INK4A^ is an important cell-cycle regulator and acts as a tumor suppressor. It inhibits the D-type cyclin-dependent kinases CDK4 and CDK6 and hence prevents the downstream phosphorylation of the retinoblastoma (Rb) pocket protein \[[@bib1]\]. This prevents release of E2 promoter binding factor 1 (E2F1), which is otherwise required for the transcriptional regulation of proteins that control controlentry into S-phase of the cell cycle \[[@bib2]\]. Accumulation of p16^INK4A^ is observed upon exposure of cells to several stressors such as oxidative stress and is one of the earliest markers of oncogenic transformation \[[@bib3]\]. The loss of p16^INK4A^ function, or loss of Rb downstream of CDK4/6, are some of the most frequently observed mutations in tumors \[[@bib4]\]. Additionally, p16^INK4A^ plays an important role in aging, as clearance of p16^INK4A^-expressing senescent cells has been shown to prolong lifespan in mice \[[@bib5],[@bib6]\].

The molecular basis of p16^INK4A^-mediated CDK4/6 inhibition is well established. p16^INK4A^ is a small, globular all-α-helical protein, that tightly binds into one side of the catalytic cleft of the CDK4/6 kinases. It efficiently distorts the cyclin D binding site, thereby blocking formation of the active CDK4/6-cyclin D complex, and preventing Rb phosphorylation \[[@bib7],[@bib8]\]. Of particular relevance for this study, the single cysteine residue (C72) present in p16^INK4A^ is located on its surface and points away from the CDK4/6 kinase in the bound state; the residue is fully solvent accessible.

Reversible cysteine oxidation is the lynchpin in redox signaling, a form of signal transduction that is regulated by the cellular redox state. A more oxidizing cellular redox state, either due to elevated reactive oxygen species or a lack of reducing power, leads to oxidative modification of specific cysteine-thiols to form reversible disulfide (S--S) bridges. These oxidative modifications can lead to structural rearrangements and can both negatively and positively regulate protein function (for a review see Ref. \[[@bib9]\]).

A number of observations spurred us to hypothesize that oxidation of p16^INK4A^ C72 could play a role in the regulation of p16^INK4A^ activity at the molecular level. Firstly, several studies have implicated a role for increased ROS in the oncogene-induced accumulation of p16^INK4A^ \[[@bib10]\], but cysteine oxidation as the underlying mechanism has thus far not been considered nor excluded. Secondly, we identified p16^INK4A^ as prone to cysteine oxidation in a large mass-spectrometry based screen for redox sensitive proteins \[[@bib11]\]. Here, we provide evidence that p16^INK4A^ itself is indeed sensitive to cysteine oxidation. We find that p16^INK4A^ is readily oxidized both *in vitro* and in cultured human cells to form a disulfide-dependent homodimer, and the oxidizing conditions required are well within the physiological range. Surprisingly, disulfide-dependent dimerization of p16^INK4A^ subsequently leads to the rapid formation of β-sheet amyloid fibril structures, a state that has not been previously described for p16^INK4A^. This transition subsequently leads to loss of CDK4/6 inhibitory capacity. Redox signaling-induced reversible disulfides have not previously been shown to induce β-sheet amyloid fibrils in other proteins and hence adds to the repertoire of redox dependent protein regulation.

2. Materials & methods {#sec2}
======================

2.1. Cell lines, plasmids, antibodies and compounds {#sec2.1}
---------------------------------------------------

Cells (HEK293T, COLO829) were cultured in DMEM low glucose supplemented with FCS (10%), [l]{.smallcaps}-glutamine (2  mM) and Penicillin-Streptomycin (100 Units-0.1  mg per ml medium) (all from Lonza). Cells were transfected using PEI (Sigma Aldrich) or X-tremeGENE 9 (Roche) according to manufacturer\'s instruction.

The vector containing the truncated form (Δ1--8) of wild type p16^INK4A^ was a gift from R. Medema \[[@bib12]\]. The cysteine mutant of p16^INK4A^ was created by site-directed pcr mutagenesis. mCherry- (backbone pLV-CMV-bc) and FLAG-His-tagged (backbone pCDNA3) and doxycycline-inducible (backbone pINDUCER20, Addgene \#44012) p16^INK4A^ constructs were created using Gateway technology (Life Technologies). COLO-829 melanoma cells stably expressing doxycyline-inducible constructs were transduced with lentivirus containing pINDUCER20-p16^INK4A^ or -p16^INK4A^C72A. Cells were selected for stable transduction using geneticin and p16^INK4A^ expression was confirmed by qPCR and western blotting. Subsequently, cells were transduced with lentivirus containing the FUCCI cell cycle probes mAG-hGeminin(1/110)/pCSII-EF (\#RDB15268) and Fucci-G1 phase probe mKO2-hCdt1(30/120)/pCSII-EF (\#RDB15267) (RIKEN BioResource Center), which were a kind gift from A. Miyawaki \[[@bib13]\]. Cells were selected for stable transduction using zeocin and made monoclonal by limiting dilution.

The following antibodies were used in this study: FLAG (M2 F3165 Sigma Aldrich), p16^INK4A^ (10883 Proteintech), p16^INK4A^ (ab16123 Abcam), CDK4 (C-22 Santa Cruz), CDK6 (C-21 Santa Cruz), tubulin (CP06 Merck Millipore), Phospho-Rb Ser807/811 (9308 Cell Signaling).

Solutions/compounds not mentioned elsewhere: 35% hydrogen peroxide (Merck).

2.2. Co-immunoprecipitation, SDS-PAGE and western blotting {#sec2.2}
----------------------------------------------------------

Immuno-precipitation of endogenous p16 was done with rabbit anti-p16^INK4A^ (10883 Proteintech) using three 10 cm dishes of HEK293T cells per sample. Transfection was performed two days prior to sample preparation. Cells were scraped in 100 mM N-ethyl-maleimide in PBS (37 °C) to prevent post-lysis oxidation and collected by centrifugation at 1200  rpm for 3 min. Cells were lysed in a standard lysis buffer containing 50 mM Tris pH 7.5, 1% Triton X-100, 1.5  mM MgCl~2~, 5 mM EDTA, 100 mM NaCl supplemented with Aprotinin, Leupeptin and NaF. 100 mM iodoacetamide was added to prevent post-lysis oxidation of cysteines. The cell lysates were subsequently centrifuged at 14000 rpm for 10 min. 50 μl of the supernatant was kept as input. For immunoprecipitation of endogenous p16^INK4A^ the pellet was resuspended in lysis buffer, sonicated and supplemented with 125 U of benzonase and incubated for 1 h at 37°. The remaining supernatant (and where indicated also the resolubilized pellet) was used for immunoprecipitation with the indicated antibody coupled to protein A-Agarose (Roche) or in case of transfected FLAG-tagged constructs with anti-FLAG M2 Affinity gel (Sigma Aldrich). After 2 h of incubation, beads were washed 3 times with standard lysis buffer supplemented with extra NaCl (1 M final concentration). After washing, samples were split into two parts, and sample buffer with or without a reducing agent (β-mercaptoethanol) was added. Samples were boiled for 5 min and separated on a 15% polyacrylamide gel. For Western Blotting, proteins were transferred to immobilon-FL membranes. For diagonal electrophoresis, non-reducing samples were separated on a 15% polyacrylamide gel, after which the entire protein containing lane was excised, reduced, and separated on a new 15% polyacrylamide gel. For visualization of diagonal electrophoresis proteins were stained by SimplyBlue.

2.3. Filter trap assay {#sec2.3}
----------------------

HEK293T cells were transfected with FLAG-p16^INK4A^, FLAG-p16^INK4A^C72A or GFP as a control. After two days, cells were scraped in 100 mM N-ethyl-maleimide in PBS (37 °C) to prevent post-lysis oxidation and collected by centrifugation at 1200 rpm for 3 min. Lysis buffer (50 mM Tris pH 7.5, 1% v/v Triton X-100, 1.5 mM MgCl~2~, 5 mM EDTA, 100 mM NaCl, Protease inhibitors (Aprotinin + Leupeptin), NaF, 100 mM iodoacetamide) added for 10 min followed by centrifugation for 15 min at 14000 rpm in an Eppendorf microfuge. The pellet was resuspended in benzonase buffer (50 mM Tris-HCL pH 8.0, 1 mM MgCl~2~) and 125 U of benzonase was added followed by incubation for 1 h at 37°. The reaction was stopped by adding 2x termination buffer (40  mM EDTA, 0.2% SDS, with or without 10 mM DTT). Protein content was measured using the BCA kit and 50 μg of protein per sample were loaded on a Bio Dot apparatus (Biorad) equipped with a 0.2 μm pore size nitrocellulose membrane soaked in buffer B (10 mM Tris-HCL pH 8.0, 150 mM NaCl, 2% SDS) on top of two Whatmann paper filters soaked in Buffer A (10 mM Tris-HCL pH 8.0, 150 mM NaCl, 1% SDS), after pre-washing the membrane with 100 μl of buffer A. Samples were pulled through the membrane using vacuum, followed by washing thrice with 100 μl of buffer A. The nitrocellulose membrane was further processed as for Western Blotting to detect trapped p16^INK4A^.

2.4. Kinase assay {#sec2.4}
-----------------

The kinase assays in this study were performed with immunoprecipitated FLAG-p16^INK4A^ or FLAG-p16^INK4A^C72A and the attached binding-partners. Beads were washed three times with standard lysis buffer followed by two washes with kinase buffer containing 25 mM Tris pH 7.5 and 10 mM MgCl~2~. The beads were subsequently incubated for 30 min at 30 °C in 20 μl kinase buffer supplemented with 1 mM DTT, 1 μg human GST-Rb (48--378 Sigma Aldrich) as substrate and 0.2 mM ATP. Directly after the assay beads were boiled for 5 min in reducing sample buffer and loaded on a 15% polyacrylamide gel followed by Western Blotting.

2.5. RNA extraction, cDNA synthesis and qPCR {#sec2.5}
--------------------------------------------

Doxycylcine-inducible p16^INK4A^ expressing Colo-829 cells were plated, and 24 h before harvesting doxycline was added to induce expression of p16^INK4A^ or p16^INK4A^C72A. Cells were treated as indicated. Cells were washed once with PBS and collected in RLT buffer. RNA was extracted using the RNeasy kit (Qiagen) according to the manufacturer\'s instructions. 1 μg RNA was used as input for cDNA synthesis using the iScript cDNA synthesis kit (Biorad). qPCR was performed with FastStart SYBR Green Master mix (Roche) using the CFX96 Touch Real-Time PCR Detection System. Relative gene expression was calculated using the ΔΔCt method \[[@bib14]\] by normalization to HNRNPA1. Statistics were done with Graphpad Prism 8. Primer sequences: *p16*^*INK4A*^ forward (5′-CAACGCACCGAATAGTTACG-3′), *p16*^*INK4A*^ reverse (5′-ACCAGCGTGTCCAGGAAG-3′), *CCNE2* forward (5′-GGGGGATCAGTCCTTGCATT-3′), *CCNE2* reverse (5′-TCCCCAGCTTAAATCAGGCA-3′), *HNRNPA1* forward (5′-GGAAGCTACAGGTTACAACA-3′), *HNRNPA1* reverse (5′-AGTCACAAATACAGTCCTCG-3′).

2.6. Protein expression and purification {#sec2.6}
----------------------------------------

An *Escherichia coli* codon-optimized gene of *Homo sapiens* p16^INK4A^ (UniProt ID: [P42771](uniprotkb:P42771){#intref0010}) was cloned into a modified version of pETM-11 that includes a 6xHis, a protein A tag and a tobacco etch virus (TEV) protease cleavage site, leaving an additional glycine residue at the N-terminal cleavage site. For a glycerol stock solution, competent *E. coli* BL21 (DE3) cells were transformed with the p16^INK4A^ harboring gene and inoculated in minimal medium in the presence of kanamycin (50 μg/l). After overnight incubation at 37 °C the cell suspension was mixed with glycerol to 50% (v/v) glycerol and stored at −80 °C. Uniformly ^15^N- and/or ^13^C-labeled protein samples were prepared from this stock by growing the cells in minimal medium containing ^15^NH~4~Cl and/or ^13^C-glucose as the only nitrogen or carbon source. The protein synthesis was induced by addition of 0.5  mM isopropyl-1-thio-[d]{.smallcaps}-galactopyranoside (IPTG) at an OD~600~ of 0.8 and cells were harvested after 14 h of induction at 19 °C. Cells were resuspended in purification buffer (110  mM potassium acetate, 20 mM HEPES \[4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid\], pH 8.0, 2 mM MgCl~2~, 2 mM β-mercaptoethanol (BME), 5% (v/v) glycerol and 20 mM imidazole) and ultrasonicated for lysis. The solution was applied to a gravity Ni-NTA agarose (QIAGEN) column following the manufacturer\'s instructions. After washing with purification buffer including 20 mM imidazole, the protein was eluted by using purification buffer including 200 mM imidazole and further purified by gel chromatography on an ÄKTA pure system equipped with a HiLoad 16/600 Superdex 75 pg column (GE Healthcare) running with purification buffer. The fractions containing the protein were pooled, incubated with 0.2 mg TEV protease overnight at 4 °C. On the following day, the protein solution was applied to the Ni-NTA agarose column again to remove the cleaved tag, remaining undigested protein and the His~6~-tagged TEV protease. The eluate was then buffer exchanged into purification buffer where BME was substituted with 1 mM DTT using dialysis. The protein solution was aliquoted, frozen in liquid nitrogen and stored at −80 °C. Solution NMR spectroscopy showed that no differences were observed after the freezing and thawing of the samples.

2.7. Solution NMR spectroscopy {#sec2.7}
------------------------------

The protein stock was freshly buffer exchanged into NMR buffer (4 mM HEPES, 5 mM EDTA, pH 7.5) before measurement. Samples for protein characterization contained 1 mM DTT (dithiothreitol) whereas samples for redox-experiments did not. The protein concentration was 0.15 mM and contained 7% (v/v) ^2^H~2~O for the lock signal. Solution ^1^H^15^N HSQC NMR spectra were measured on an Avance III 600 Bruker NMR spectrometer equipped with a cryogenic triple resonance probe with gradients in the z-direction. The recycle delay of the redox experiments performed was set to 1 s with a spectral window of 11/34 ppm in ^1^H/^15^N dimensions, 2048 points in the direct ^1^H dimension, 128 complex data points in the indirect ^15^N dimension, and with 8 or 16 scans per increment. Spectra were processed with the NMRPipe package \[[@bib15]\] and analyzed by CcpNmr Analysis \[[@bib16]\].

For determination of the S-glutathionylation redox potential, the concentration of GSSG in the sample buffer was gradually increased (0.2; 1.0; 2.3; 3.3; 3.9; 5.9; 7.8; 8.8; 9.8; 11.7 mM) by titrating from a 65  mM pH corrected stock solution while the concentration of the reduced form of GSH was kept constant at 4 mM. At each concentration point, a ^1^H^15^N HSQC NMR spectrum was recorded immediately after addition of the oxidation agent. For assignment of the S-GSHylated protein, HNCA and CBCACONH spectra were acquired. Determination of the redox potential was performed following the protocol of Piotukh et al. \[[@bib17]\]. In summary, peak intensities of well isolated peaks (N71, C72, D74, T79) of the oxidized form were normalized to a non-affected asparagine side chain resonance and plotted against the redox potential of the buffer. This potential was determined from the standard half-cell potential of the glutathione redox couple (−240 mV at pH 7.0, 25 °C) after pH corrections \[[@bib18]\]. The data were fitted to the sigmoidal decay function (equation [(1)](#fd1){ref-type="disp-formula"}):$$y = A_{2} + \frac{(A_{1} - A_{2})}{1 + e^{\frac{x - x_{0}}{dx}}}$$where A~1~ and A~2~ are the initial and final plateaus of the function, dx is the slope and x~0~ refers to the desired parameter of the redox potential.

For oxidized samples of p16^INK4^, a final concentration of 50 mM hydrogen peroxide (H~2~O~2~, from a 30% solution diluted with NMR buffer) or 100 μM diamide (from a freshly prepared 10  mM stock solution in H~2~O) was added to the ^15^N-labeled protein solution. ^1^H^15^N HSQC NMR spectra were acquired after the addition of the oxidizing agent in subsequent manner. After 10 h, no spectral changes were observed for WT protein anymore and the sample was applied to a size exclusion column (HiLoad 10/300 Superdex 75 pg column, GE Healthcare) and the aggregated fraction was pooled. The protein was applied to SDS gel electrophoresis in the presence and absence of BME.

2.8. CD spectroscopy {#sec2.8}
--------------------

Far-UV CD experiments were recorded on a J-715 spectropolarimeter (Jasco, Tokyo, Japan). Spectra were acquired at room temperature with a response time of 1 s and a step resolution of 0.3 nm. Five scans were averaged and the signal was background corrected by subtraction of the buffer signal. The CD spectra were obtained from a 1 μM p16^INK4A^ sample before and after oxidation with 200 μM hydrogen peroxide for 8 h at room temperature and data were converted to molar ellipticity. Samples were freshly prepared and transferred into a 10 mM sodium phosphate buffer at pH 7.4 in the absence of reducing agents.

2.9. Small-angle X-ray scattering measurements {#sec2.9}
----------------------------------------------

SAXS data was recorded on an in-house SAXS instrument (SAXSess mc2, Anton Paar, Graz, Austria) equipped with a Kratky camera, a sealed X-ray tube and a two-dimensional Princeton Instruments PI•SCX:4300 (Roper Scientific) CCD camera. Measurements were performed with 90 min exposure time (540 frames of 10 s each) of three concentrations of 2.5 mg/ml, 1.25 mg/ml and 0.625 mg/ml in NMR buffer. The sample of reduced p16^INK4A^ was measured immediately after purification and buffer exchange. The oxidized sample of p16^INK4A^ was treated overnight with 50 m M H~2~O~2~ at room temperature. Next day, the sample was applied to size exclusion chromatography and the peak from 9 to 10  ml elution volume was pooled (see [Figs. S6 and B](#appsec1){ref-type="sec"}) and concentrated. Individual frames of the 90 min exposure were compared and no radiation damage was observed. A range of momentum transfer of 0.012 \< s \< 0.63 Å^−1^ was covered (s = 4π sin(θ)/λ, where 2θ is the scattering angle and λ = 1.5 Å is the X-ray wavelength). SAXS data were analyzed with the package ATSAS version 2.8.1 \[[@bib19]\]. Desmearing of the oxidized sample could not be performed because the scattering curve showed strong aggregation.

2.10. Thioflavin-T fluorescence assay {#sec2.10}
-------------------------------------

Samples of p16^INK4A^ (20 μM) were prepared in buffer (4  mM HEPES, pH 7.5) with 20 μM ThT. Three replicates were measured for each sample. Samples were subjected to 1 mm orbital shaking for 2 min of every 5 min, in a 96-well, half-area, fluorescence plate (Corning) and measurements were taken every 5 min. Samples were excited at 440 nm and fluorescence emission was measured at 480 nm. Measurements were made using a Tecan GENios microplate reader.

2.11. Negative-stain transmission electron microscopy {#sec2.11}
-----------------------------------------------------

Protein samples were prepared by incubation of p16^INK4A^ samples with or without oxidizing agents for 6--24 h at RT. Copper grids with 300 meshes coated with formvar/carbon film (Electron Microscopy Sciences, Hatfield, USA) were glow-discharged in argon atmosphere for 30 s at 3 mA. Grids were floated on a 5  μl drop of a 50 μM protein sample and incubated for 60 s. Grids were washed once with water, and then floated on 5 μl of uranyl acetate solution (2% w/v) for 30 s. Micrographs were taken on either a JEOL JEM 100CX transmission electron microscope or a JEOL JEM 1400 Plus transmission electron microscope (JEOL, Tokyo, Japan).

2.12. Prediction of aggregation-prone regions {#sec2.12}
---------------------------------------------

Four different aggregation prediction programs, TANGO \[[@bib20]\], PASTA \[[@bib21]\], Zyggregator \[[@bib6]\] and Aggrescan \[[@bib22]\] were used to identify putative regions responsible for the beta-aggregation of p16^INK4A^ using the default settings.

2.13. Congo-red absorbance {#sec2.13}
--------------------------

Absorbance spectra were measured on samples of p16^INK4A^ (20 μM) with Congo red (20  μM) in buffer (4 mM HEPES, pH 7.5). Spectra were recorded from 400 to 650 nm, with a resolution of 2 nm, on a Tecan Infinite 200Pro microplate reader in a 96-well plate (Corning).

2.14. Fourier-transform infrared spectroscopy {#sec2.14}
---------------------------------------------

p16^INK4A^ (80 μM) samples were treated with 50 mM H~2~O~2~ overnight in buffer (4 mM HEPES pH 7.5), then dialysed against water overnight. Spectra were recorded on a JASCO FT/IR-4100 FT-IR spectrometer with attenuated total reflectance (ATR) attachment. The samples were measured with 128 scans at a resolution of 2 cm^−1^ at room temperature.

2.15. Solid-state NMR spectroscopy {#sec2.15}
----------------------------------

10 mg (150 μM) of ^13^C--^15^N labeled p16^INK4A^ fibrils were prepared in buffer (4 mM HEPES pH 7.5) by addition of 50 m M H~2~O~2~ and incubation at 37 °C overnight. The sample was packed into a 3.2 mm MAS rotor by ultracentrifugation. Spectra were recorded on a Bruker Avance III 750 MHz spectrometer (Bruker BioSpin) equipped with a 3.2 mm triple-resonance MAS probe. A proton-driven spin diffusion (PDSD) spectrum \[[@bib23]\] was recorded at 16.5 kHz MAS, with 50 ms mixing time, at a set temperature of 273 K, with 352 scans and 22  ms and 8  ms acquisition time in the direct and indirect dimensions, respectively. Experiments were acquired using Topspin 3.2 (Bruker Biospin) and analyzed using CCPN Analysis 2 \[[@bib16]\] The secondary chemical shift was calculated as \[δ(Cα~observed~) -- δ(Cα~random\ coil~)\] -- \[δ(Cβ~observed~) -- δ (Cβ~random\ coil~)\] with random coil chemical shifts taken from Ref. \[[@bib24]\].

2.16. Sample preparation for mass spectrometry {#sec2.16}
----------------------------------------------

HEK293T cells were transfected with FLAG-p16^INK4A^ or FLAG-p16^INK4A^ C72A. After two days, half of the dishes (3 full 15 cm dishes per sample) were treated for 10 min with diamide (250 μM) (Sigma Aldrich) and subsequently harvested for immunoprecipitation with FLAG beads as described before. After washing 2x with 1 M salt buffer and 3x with PBS to remove all soap, proteins were eluted from the beads by two times 5 min incubation with 75  μl 0.1 M glycine pH 2. The protein containing supernatant was transferred to a new tube and incubated for 20 min with 10 mM DTT and 2 M Urea (dissolved in 100 mM Tris pH 7.5), followed by 10 min incubation with iodoacetamide (50 mM). To digest the proteins, 0.25 μg trypsin (Promega) was added per sample and samples were incubated ON at 25 °C. The next day C18‐stagetips were used for filtering and loading of the protein digest.

2.17. Mass spectrometry and data analysis {#sec2.17}
-----------------------------------------

The mass spectrometry was performed as previously described \[[@bib11]\].

For the analysis Maxquant software version 1.5.1.0 \[[@bib25]\] was used. During the analysis, oxidation of methionine, alkylation of cysteines with iodoacetamide were set as variable modification. Proteins were identified by the IPI human V3.68 database and the relative amounts of protein in the separate experiments, the Intensity Based Absolute Quantification (IBAQ) \[[@bib26]\], as well as the label free quantification \[[@bib27]\] were calculated.

Further analysis was done using R version 3.4.0. The used code and description is currently being uploaded to GitHub. Proteins identified with two or more unique peptides were filtered for reverse hits, decoy hits and standard contaminants and samples that show aberrant clustering or low protein count were excluded. Subsequently the IBAQ data was Log2 transformed and normalized for IP efficiency. For p-value calculations, left-censored missing data was first imputed using a stochastic minimal value approach. Imputation was performed by random draws from a Gaussian distribution centered in the 10^−4^ quantile of the known data with a standard deviation that is same as the observed values \[[@bib28]\] A standard *t*-test was performed on the imputed data and p-values were adjusted for multiple testing using the Benjamini-Hochberg correction.

2.18. Mass spectrometry of GS-p16^INK4A^ {#sec2.18}
----------------------------------------

The intact mass of p16^INK4A^ before and after oxidation by GSSG was obtained from LC-MS analysis, that was performed on recombinantly expressed protein (see protein expression and purification section). The sample was desalted using 10 kDa Amicon Ultra-0.5 centrifugal filter devices prior to measurement. 150 pmol of protein were injected into an Agilent 1200 system (Vienna, Austria) coupled to an LTQ-FT mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). Separation was carried out on a monolithic PepSwift® column (500  μm × 5 cm Monolithic PS -- DVB) at a flow rate of 20 μl/min using the following gradient, where solvent A is 0.05% trifluoroacetic acid in water and solvent B is 0.05% trifluoroacetic acid in acetonitrile: 0--5 min: 10% B; 5--55  min: 10--100% B; 55--65 min: 100% B, 65--80 min: 10% B. The sample was ionized in the electrospray source and analyzed using FT-MS operated in positive ion mode applying full scan MS (*m*/*z* 300 to 2000) with a resolution of 400,000. Acquired data were processed with the software Protein Deconvolution 2.0 SP2 (Thermo Fisher Scientific) using a S/N threshold of 5 and a relative abundance threshold of 20%.

2.19. Flow cytometry {#sec2.19}
--------------------

Cell cycle analysis was performed using a combination of the FUCCI \[[@bib13]\] system and DNA content staining. COLO-829 cells expressing the FUCCI constructs as well as pINDUCER20-p16^INK4A^ or p16^INK4A^-C72A were seeded and treated with doxycycline and LEE-011 for the indicated times and samples. Nocodazole was added 16 h before harvest to capture cycling cells in mitosis to distinguish transient G1 from G1/G0 arrested cells. Cell culture medium was collected and cells were washed in PBS before trypsinization. Cells were fixed for 10 min at room temperature with 2% formalin in PBS. After 2 washes with PBS, cells were permeabilized with 70% ethanol for 30 min. Cells were resuspended in PBS with 0.1% BSA with DAPI and RNAse to stain the DNA. mKO2-hCtd1(30/120), mAG-hGeminin(1/110) and DAPI were measured using a BD FACSCelesta Flow Cytometer (BD Bioscience).

2.20. Evolutionary analysis {#sec2.20}
---------------------------

Amino acid sequences of vertebrate orthologues of human p16^INK4A^ and p15^INK4B^ were downloaded from the ENSEMBL database \[[@bib29]\]. Alignment and visualization of conservation was performed using JalView 2.10.1 software \[[@bib30]\], with the Clustal plugin with default settings.

3. Results {#sec3}
==========

3.1. p16^INK4A^ is oxidized to form disulfide dependent homodimers in human cells {#sec3.1}
---------------------------------------------------------------------------------

To test whether p16^INK4A^ forms disulfide-dependent complexes under oxidizing conditions, immunoprecipitation followed by non-reducing SDS-PAGE was performed. Oxidation was induced using a concentration series of either hydrogen peroxide or the thiol-specific oxidant diamide (tetramethylazodicarboxamide) that ranged from subtoxic (5 μM) to mildly toxic (250  μM) in HEK293T cells. FLAG-p16^INK4A^ readily formed intermolecular disulfide-dependent complexes ([Fig. 1](#fig1){ref-type="fig"}A), as judged by the large mobility shift under non-reducing conditions, that was abolished when the samples were reduced prior to SDS-PAGE (last lanes). Note that only the FLAG-p16^INK4A^ disulfide-dependent dimer band is observed and that its intensity increases upon exposure to increasing oxidant concentration. We did not observe a "smear", which would occur if p16^INK4A^ were to undergo random, nonspecific crosslinking to proteins. We then created p16^INK4A^ mutants in which the only cysteine was replaced by alanine (C72A) or serine (C72S). We opted to use p16^INK4A^-C72A for our further experiments in human cells in order to circumvent the potential effects of the introduction of a novel phosphorylation site in the C72S mutant. The C72A mutant is still functional as a cell-cycle inhibitor and hence the mutation does not grossly affect protein function per se ([Fig. S1](#appsec1){ref-type="sec"}). To explore whether the observed intermolecular disulfide-dependent complexes are FLAG-p16^INK4A^ homodimers, Co-IP experiments were performed using combinations of wild-type (WT) p16^INK4A^ and C72A with short (FLAG) and long (mCherry) N-terminal tags. Under non-reducing conditions, bands could be observed corresponding to disulfide-dependent dimers of FLAG-p16^INK4A^-S-S-FLAG-p16^INK4A^ and of mCherry-p16^INK4A^-S-S-FLAG-p16^INK4A^ ([Fig. S2A](#appsec1){ref-type="sec"}) after FLAG pull down. Furthermore, diagonal electrophoresis showed that after reduction (2nd dimension) FLAG-p16^INK4A^ drops out of the diagonal as a single dot, whereas a heterodimer would have revealed a second Simply Blue stained protein with similar intensity dropping out of the diagonal ([Fig. S2B](#appsec1){ref-type="sec"}). To test the dynamics of the intermolecular disulfide-dependent dimerization of p16^INK4A^, a time course of oxidant treatment was performed, using p16^INK4A^-C72A as a control. The oxidation of p16^INK4A^ was rapid, peaked after 10 min, was fully dependent on the only cysteine and was resolved upon boiling in reducing sample buffer ([Fig. 1](#fig1){ref-type="fig"}B).Fig. 1**p16**^**INK4A**^**forms intermolecular disulfides upon exposure to oxidants.(A)** Analysis of Immuno-precipitated FLAG-p16^INK4A^ by non-reducing SDS-PAGE and Western Blot shows that part of the FLAG-p16^INK4A^ migrates at about double the molecular weight upon 5 min treatment with low amounts of the thiol-specific oxidant diamide (left panel) or H~2~O~2~ (right panel). Reduction (R) prior to SDS-PAGE abolishes the shift in molecular weight, indicating that it is indeed due to an intermolecular disulfide (see also [Figs. S2A and S2B](#appsec1){ref-type="sec"} for confirmation that the high molecular weight form of p16^INK4A^ is an S--S-dependent homodimer).**(B)** S--S-dependent p16^INK4A^ homodimerization upon 200 μM diamide (left) or 200 μM  H~2~O~2~ (right) occurs rapidly, coincides with accumulation of p16^INK4A^ protein levels and oxidation as well as accumulation are fully dependent on C72.**(C)** Endogenous p16^INK4A^ and over-expressed FLAG-p16^INK4A^ accumulate in response to 200 μM diamide with similar kinetics. Note that p16^INK4A^C72A does not accumulate whereas endogenous p16^INK4A^ does, suggesting that endogenous p16^INK4A^ levels are also regulated by Cys-oxidation. (IP: immunoprecipitation, WB: Western Blot). All Western blots shown in [Fig. 1](#fig1){ref-type="fig"} are typical results of several repeats (N ≥ 3 for all experiments).Fig. 1

Concomitantly with its oxidation, p16^INK4A^ protein abundance increased, and this was again dependent on its single cysteine residue. Protein levels already increased after a few minutes of diamide treatment, excluding a role for gene transcription but suggestive of a role for decreased protein breakdown. The accumulation is best observed using reducing SDS-PAGE because all p16^INK4A^ then migrates in a single band ([Fig. 1](#fig1){ref-type="fig"}B and C). The increased p16^INK4A^ protein levels rapidly returned to basal upon diamide wash-out with fresh media ([Fig. 1](#fig1){ref-type="fig"}C). Endogenous p16^INK4A^ levels follow the same trend as FLAG-p16^INK4A^ indicating that endogenous p16^INK4A^ is also regulated through cysteine oxidation. Taken together, both the increase in p16^INK4A^ levels as well as the oxidation are dependent on C72.

3.2. C72 of p16^INK4A^ is readily oxidized *in vitro* {#sec3.2}
-----------------------------------------------------

To study the reactivity of the p16^INK4A^ cysteine residue directly, we expressed and purified the isotope-labeled recombinant protein and confirmed its correct folding by solution nuclear magnetic resonance (NMR) spectroscopy. Upon treatment of the purified protein with oxidized glutathione (GSSG), we observed chemical shift changes that occurred most strongly in proximity to the cysteine residue of p16^INK4A^ ([Fig. 2](#fig2){ref-type="fig"}A and B, [Fig. S3](#appsec1){ref-type="sec"}). These changes were reversed by addition of the reducing agent DTT, confirming the involvement of reversible cysteine oxidation. Mass spectrometric analysis of the intact protein showed that p16^INK4A^ was S-glutathionylated (S-GSHylated) after treatment with GSSG ([Fig. S4](#appsec1){ref-type="sec"}). S-GSHylation of the protein does not change its monomeric state or overall fold, as indicated by identical peak line shapes and unchanged elution times in size exclusion chromatography. By titrating the reduced p16^INK4A^ sample with increasing GSSG in a GSH/GSSG redox buffer we determined the redox potential of C72 using the Nernst equation \[[@bib17]\] to be −198.3±1.7 mV ([Fig. 2](#fig2){ref-type="fig"}C).Fig. 2***In vitro*****oxidation of p16**^**INK4A**^**(A)**^1^H^15^N HSQC solution NMR spectrum of recombinant p16^INK4A^ in the reduced state (blue) and after S-glutathionylation (magenta). Amino acids with large chemical shift changes are labeled.**(B)** Cartoon representation of the p16^INK4A^ structure. A color gradient from white (unaffected) to red (strongly affected) shows the influence of S-glutathionylation on the chemical shift.**(C)** The redox potential of C72 is 198.3 ± 1.7 mV, as determined from intensity changes of four well-separated amino acids by titration of the reduced protein with oxidized glutathione. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

To study the structural role of the cysteine residue, we used the p16^INK4A^-C72S mutant, which is the most structurally conservative mutation, differing only by replacement of the sulfhydryl group with a hydroxyl group. This mutant showed monomeric behavior during purification and largely identical chemical shifts as compared to the wild-type protein ([Fig. S5](#appsec1){ref-type="sec"}), indicating that the mutation does not affect p16^INK4A^ protein structure per se. Addition of GSSG to this mutant did not show any indications of interaction or covalent modification. Collectively, these experiments indicate that the p16^INK4A^ C72 can be directly oxidized *in vitro* at physiologically occurring redox states.

3.3. Disulfide-dependent homo-dimerization of p16^INK4A^ triggers aggregation {#sec3.3}
-----------------------------------------------------------------------------

The use of GSSG as an oxidant resulted in p16^INK4A^ S-GSHylation *in vitro*, whereas experiments in human cells showed S--S-linked homodimerization ([Fig. 1](#fig1){ref-type="fig"}) upon treatment with diamide or H~2~O~2~, even though both these agents lead to increased GSSG in cells. We therefore assessed whether H~2~O~2~ and diamide can directly oxidize p16^INK4A^ *in vitro*. SDS-PAGE analysis revealed that disulfide-linked protein homodimers are also formed *in vitro*, similar to the pattern observed in the experiments in human cells ([Fig. S6A](#appsec1){ref-type="sec"}). Comparison of size exclusion chromatography traces of reduced and oxidized samples show that oxidation of p16^INK4A^ causes a shift to high molecular mass, with the oxidized sample eluting in the void volume of the column ([Fig. S6B](#appsec1){ref-type="sec"}). In contrast to oxidation by GSSG, the addition of either H~2~O~2~ ([Fig. 3](#fig3){ref-type="fig"}A) or diamide ([Figs. S6C and S6D](#appsec1){ref-type="sec"}) led to strong NMR chemical shift changes that indicated protein unfolding and aggregation. This indicates the formation of a multimeric species and the absence of monomeric p16^INK4A^. Characterization of reduced and oxidized WT p16^INK4A^ by Circular Dichroism (CD) spectroscopy revealed a transition to a less structured species, with some alpha-helical characteristics remaining ([Fig. S7A](#appsec1){ref-type="sec"}). Small-angle X-ray scattering (SAXS) on the oxidized samples indicates that the aggregates are larger than the detection limit of about 400 nm diameter ([Fig. S7B](#appsec1){ref-type="sec"}). S-Glutathionylation of p16^INK4A^ C72 would abolish its reactivity towards diamide or H~2~O~2~. To exclude that the observed aggregation of p16^INK4A^ stems from modifications other than C72, we also performed solution NMR spectroscopy on the S-glutathionylated p16^INK4A^ (GS-p16^INK4A^), as well as on the p16^INK4A^-C72A mutant, treated with diamide or H~2~O~2~. No chemical shift changes were observed and the monomeric, S-glutathionylated protein sample as well as the p16^INK4A^-C72A mutant were stable in presence of oxidizing agents ([Fig. S8](#appsec1){ref-type="sec"}). Together, these experiments indicate the formation of an aggregated p16^INK4A^ species upon intermolecular disulfide bond formation *in vitro*.Fig. 3**p16**^**INK4A**^**forms amyloid fibrils under oxidizing conditions(A)**^1^H,^15^N HSQC solution NMR spectra of recombinant p16^INK4A^ before (blue) and after (orange) oxidation with 50  mM  H~2~O~2~ for 10  h  at room temperature (orange). The collapse of the peaks to the center of the spectrum suggests formation of unstructured or aggregated protein.**(B)** Negative-stained transmission electron micrographs of diamide-treated p16^INK4A^ showing the presence of amyloid fibrils. Right panel is at higher magnification, arrows highlight the twisted morphology which is typical of amyloid fibrils.**(C)** Fibril formation of p16^INK4A^ monitored by thioflavin-T fluorescence measurement. Error bars represent standard deviation from four measurements.**(D)** Fibril formation of p16^INK4A^ monitored by Congo red absorption. The absorption maximum shifts when bound to oxidized p16^INK4A^, indicating the presence of amyloid fibrils.**(E)** Amide I region of the attenuated-total-reflectance Fourier-transform infrared spectra of p16^INK4A^ monomer and fibrils. Peak maxima indicate that the structure contains primarily α-helix for monomers and cross-β sheet for fibrils. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 3

3.4. Disulfide-linked homodimers of p16^INK4A^ form β-amyloid fibrils {#sec3.4}
---------------------------------------------------------------------

Based on the indications of aggregation, transmission electron microscopy (EM) was employed to study the nature of the p16^INK4A^ aggregates that formed upon oxidation. Interestingly, we found that the oxidized p16^INK4A^ samples produced fibrillar structures ([Fig. 3](#fig3){ref-type="fig"}B). One prominent group of fibrillar proteins are amyloid fibrils, which are characterized by a cross-β sheet core structure, meaning that β-strands run perpendicular to the fibril long axis \[[@bib31],[@bib32]\]. To determine if p16^INK4A^ fibrils are amyloid, we used the amyloid-specific dyes Thioflavin T (ThT) and Congo Red \[[@bib33], [@bib34], [@bib35]\]. ThT assays showed an increase in fluorescence, which is characteristic for amyloids, when bound to oxidized p16^INK4A^ ([Fig. 3](#fig3){ref-type="fig"}C), while Congo Red absorbance measurements showed the red shift and increased absorbance characteristic of amyloid binding ([Fig. 3](#fig3){ref-type="fig"}D). Fourier-transform infrared spectroscopy can distinguish cross β-sheets found in amyloid fibrils from β-sheets found in globular monomeric proteins \[[@bib36],[@bib37]\]; in line with the dye-binding data, p16^INK4A^ fibrils had a maximum at 1620 cm^−1^, which falls within the typical amyloid β-sheet region, confirming the amyloid structure of the fibrils ([Fig. 3](#fig3){ref-type="fig"}E). We performed a computational analysis using four fibril prediction algorithms \[[@bib20], [@bib21], [@bib22],[@bib38]\] and all suggested a high propensity for β-amyloid formation in the region from residue no. 91--99 ([Fig. S9A](#appsec1){ref-type="sec"}).

Additionally, we recorded solid state NMR spectra on a uniformly ^13^C-labeled p16^INK4A^ sample to confirm the secondary structure of the aggregated state. Samples were prepared using the same conditions that were used for other experiments including electron microscopy, to ensure that results are comparable between experiments. In ^13^C--^13^C correlation spectra, only amino acid residues within a structured core are visible ([Fig. S9](#appsec1){ref-type="sec"}). The spectrum shows relatively few peaks compared to the 156 residues of full-length p16^INK4A^, suggesting that only specific parts of the sequence form the structural core of the amyloid fibrils. This is also indicated by the absence of certain residue types from the spectrum, for example isoleucine ([Fig. S9B](#appsec1){ref-type="sec"}). Many of the peaks could be assigned to their amino-acid type due to their distinctive Cα and Cβ peak positions, which allowed for determination of the secondary structure. Nearly all assigned peaks have peak positions that are characteristic for β-sheet or random coil ([Fig. S9C](#appsec1){ref-type="sec"}), confirming that p16^INK4A^ aggregates have a β-sheet core and are therefore amyloid. These findings emphasize the dramatic structural rearrangement from the monomeric eight-α-helical bundle that is devoid of β-sheets.

3.5. Intermolecular p16^INK4A^ disulfide bond formation is essential for amyloid fibril assembly {#sec3.5}
------------------------------------------------------------------------------------------------

We further investigated the role of oxidation of the cysteine residue in fibril formation by comparing the p16^INK4A^ WT protein to p16^INK4A^-C72S. Electron microscopy revealed that upon treatment with as little as 200  μM  H~2~O~2~ or diamide, WT samples formed large fibrillar structures ([Fig. 4](#fig4){ref-type="fig"}A, top panels). There was no discernible difference between the morphology of fibrils formed with diamide or H~2~O~2~ treatment, or when higher concentrations of oxidizing agent were used. p16^INK4A^-C72S samples displayed a very different morphology, instead forming unordered, amorphous aggregates, as well as a small amount of short fibrillar species ([Fig. 4](#fig4){ref-type="fig"}A, middle panels).Fig. 4**C72 is important for fibrillar morphology and ThT binding.(A)** Negative-stain transmission electron micrographs of p16^INK4A^ treated with 200  μM hydrogen peroxide (left) and 200  μM diamide (right). Top: WT p16^INK4A^. Middle: p16^INK4A^-C72S. Bottom: GS-p16^INKA^.**(B)** Thioflavin-T fluorescence kinetics assay of p16^INK4A^ samples (WT, C72S and GS) with 200  μM diamide addition (top) 200  μM  H~2~O~2~ addition (middle) and without oxidizing agents (bottom). Three replicates were measured per sample and each are separately plotted.Fig. 4

Glutathionylated-p16^INK4A^ (GS-p16^INK4A^) samples were also analyzed by electron microscopy, and were found to form large, granular aggregates without any fibrils upon treatment with either H~2~O~2~ or diamide ([Fig. 4](#fig4){ref-type="fig"}A, bottom panels). Although aggregates are seen by electron microscopy, the solution NMR spectra of GS-p16^INK4A^ indicate the sample is largely soluble and monomeric ([Fig S8A, S8B](#appsec1){ref-type="sec"}), suggesting that the aggregates seen by electron microscopy constitute only a small proportion of the total GS-p16^INK4A^ protein.

We next investigated the influence of intermolecular disulfide bond formation on the kinetics of fibril formation, by measuring the time- and oxidation-dependence of p16^INK4A^ WT, p16^INK4A^ C72S and GS-p16^INK4A^ variants using the ThT assay ([Fig. 4](#fig4){ref-type="fig"}B). Upon treatment of WT p16^INK4A^ with oxidizing agents, the sample fluorescence rapidly increased as ThT-positive fibrils were formed, with maximum signal being achieved within 2 h upon 200 μM diamide treatment ([Fig. 4](#fig4){ref-type="fig"}B, top) and more than 16 h for 200 μM H~2~O~2~ treatment ([Fig. 4](#fig4){ref-type="fig"}B, middle), while no fibrils were formed in the absence of oxidizing agents ([Fig. 4](#fig4){ref-type="fig"}B, bottom). The C72S mutant displayed only a very slight increase in fluorescence over time, and this was not affected by the presence or absence of oxidizing agents. GS-p16^INK4A^ did not form ThT-positive aggregates under any condition. The amyloids formed *in vitro* were reversible: boiling in non-reducing sample buffer for 5 min prior to SDS-PAGE resulted mainly in detection of the S--S-dependent dimers ([Fig. S10](#appsec1){ref-type="sec"}). The EM and ThT-kinetics data emphasize that the amorphous aggregates observed by EM for the p16^INK4A^-C72S and GS-p16^INK4A^ are not amyloid, both by morphology and by dye-binding properties. Therefore, we conclude that the intermolecular disulfide bond formation of p16^INK4A^ through C72 is critical for the formation of p16^INKA^ amyloid fibrils.

3.6. p16^INK4A^ cysteine oxidation triggers its aggregation in cultured cells {#sec3.6}
-----------------------------------------------------------------------------

Having shown that p16^INK4A^ forms amyloid fibrils upon oxidation *in vitro*, we investigated to what extent this behavior was conserved in cultured human cells. HEK293T cells expressing FLAG-tagged p16^INK4A^ WT and p16^INK4A^ C72A mutant were exposed to diamide and processed for a filter trap assay: an assay that is commonly used to detect amyloids in cell extracts (Scheme top of [Fig. 5](#fig5){ref-type="fig"}A). Exposure to diamide prior to lysis rapidly led to accumulation of the p16^INK4A^ homodimer in the solubilized pellet fraction and subsequent trapping of p16^INK4A^ on the filter membrane, and both were dependent on C72. Reduction of the protein lysates with DTT prior to washing abolished trapping, suggesting that the aggregation was reversible ([Fig. 5](#fig5){ref-type="fig"}B). Clearance of p16^INK4A^ aggregates was observed over time after diamide treatment. After 120 min the aggregates were largely resolved ([Fig. 5](#fig5){ref-type="fig"}C), reminiscent of turnover of the disulfide-linked homodimer in [Fig. 1](#fig1){ref-type="fig"}C.Fig. 5**p16**^**INK4A**^**aggregates in live cells in response to oxidation.(A)** Set up for the Filter Trap assay for the detection of aggregates in cell lysates.**(B)** Results for the Filter Trap assay. Note that the majority of p16^INK4A^ in the pellet is in the form of S-S-linked homodimers after lysis. p16^INK4A^, but not p16^INK4A^C72A, was trapped on the filter membrane upon treatment with 200 μM diamide and trapping was prevented by pretreatment with DTT. Equal amounts of p16^INK4A^ and p16^INK4A^C72A were used as input for the filter trap assay. Note that the input for the Filter Trap assay runs mainly as a S--S-dependent dimer after boiling in non-reducing SDS-PAGE sample buffer. R: reducing, NR: non-reducing.**(C)** Aggregates of p16^INK4A^ peak around 30  min and are then cleared over time.**(D)** Endogenous p16^INK4A^ also forms S--S-linked dimers that (partially) form aggregates in the insoluble pellet fraction. Note that also mixed S--S-linked dimers of endogenous and overexpressed p16INK4A can be observed in lanes where FLAG-p16INK4A was transfected. n.i.: IP with non-immune serum as a control. p16(r): rabbit anti-p16INK4A, p16(m): mouse anti-p16INK4A, e.v.: empty vector, Red: reducing, Non-Red: non-reducing. All experiments were performed at least 3 times. Representative experiments are shown.Fig. 5

We also studied whether oxidation induced the aggregation of endogenous p16^INK4A^, for which the expression levels are generally lower than those of transfected FLAG-p16^INK4A^. We found that endogenous p16^INK4A^ also forms disulfide-linked dimers upon oxidation and that part of these accumulate in the insoluble pellet fraction ([Fig. 5](#fig5){ref-type="fig"}D). Similar amounts of endogenous p16^INK4A^ are found in the solubilized pellet fraction in the presence and absence of transfected FLAG-p16^INK4A^, suggesting that endogenous p16^INK4A^ levels are sufficient to form homodimers and aggregates (see Reducing IP panels). The phase-transition from monomeric to the amyloid form of p16^INK4A^ would likely change its biochemical properties and protein-protein interactions. To test this, the interactomes of immunoprecipitated FLAG-p16^INK4A^ and FLAG-p16^INK4A^C72A were investigated and compared by label-free quantitative mass spectrometry. Under basal conditions the interactomes were largely identical, but this changed dramatically upon diamide treatment ([Fig. S11](#appsec1){ref-type="sec"}). Diamide-treated WT p16^INK4A^ indeed showed a large number of binding partners not identified in diamide-treated p16^INK4A^-C72A pull-downs. The interaction with CDK4 and CDK6 was not affected by diamide treatment or the C72A mutation. Proteins that form amyloids are known to bind to chaperones and indeed several Heat Shock Proteins were found to interact with WT p16^INK4A^ upon diamide treatment, again indicative of aggregate formation.

3.7. p16^INK4A^ cysteine oxidation restores CDK4/6 kinase activity {#sec3.7}
------------------------------------------------------------------

We then investigated how the p16^INK4A^ function as a CDK4/6 inhibitor would be affected by amyloid formation. CDK4/6 was co-immunoprecipitated with FLAG-tagged p16^INK4A^, and *in vitro* kinase assays were performed using a GST-tagged Rb fragment as a substrate (Scheme [Fig. 6](#fig6){ref-type="fig"}A). These experiments revealed that oxidation of WT p16^INK4A^ or p16^INK4A^-C72S did not greatly affect the binding to CDK4/6 ([Fig. 6](#fig6){ref-type="fig"}A), which agrees with our observations in the MS experiments ([Fig. S11](#appsec1){ref-type="sec"}). The *in vitro* kinase assay showed that p16^INK4A^-associated CDK4/6 was, as expected, inactive under basal conditions. CDK4/6 activity towards the GST-Rb fragment was regained when cells were exposed to diamide prior to lysis, despite the increased amount of p16^INK4A^ that was pulled down. The reactivation was strictly dependent on p16^INK4A^ C72. Taken together, these observations suggest that the amyloid form of p16^INK4A^ still interacts with CDK4/6 but in a manner that does not lead to kinase inhibition.Fig. 6**Oxidation of p16^INK4A^ impairs its inhibitory function towards CDK4/6.(A)** In vitro CDK4/6 kinase assay on WT p16^INK4A^ pulldowns shows that the oxidation of p16^INK4A^-C72 impairs its inhibitory function. Note that oxidation or mutation of Cys72 does not affect the amount of CDK4/6 that is co-immunoprecipitated. (R: Reducing, NR: Non-reducing). All Western blots shown in [Fig. 6](#fig6){ref-type="fig"} are typical results of several repeats (N ≥ 3 for all experiments).**(B)** qPCR analysis showing the expression of WT p16^INK4A^WT or p16^INK4A^-C72A (top) in COLO-829 cells upon induction of expression from the respective pINDUCER20-p16^INK4A^ construct. CCNE2 expression (bottom) is strongly repressed both by WT p16^INK4A^ and p16^INK4A^-C72A. Diamide treatment relieves this repression only in the WT p16^INK4^ expressing cell line. Note that the inducible system is somewhat leaky, which could explain induction of CCNE2 in the p16^INK4A^WT cells by diamide in the absence of doxycycline. The mean plus SEM is displayed from n = 5 biological replicates. \*p \< 0.05, \*\*p \< 0.01, pairwise comparison using a two-sided *t*-test comparing cells carrying the inducible WT p16^INK4^ or p16^INK4A^-C72A construct in each condition.Fig. 6

To test how p16^INK4A^ oxidation and aggregation impacts on the total CDK4/6 activity we performed qPCR analysis on the expression of Cyclin E2 (CCNE2), which is a transcriptional target of E2F1 and hence should be upregulated by active CDK4/6. CCNE2 ([Fig. 6](#fig6){ref-type="fig"}B, lower panel) was strongly repressed upon the doxycycline-induced p16^INK4A^ or p16^INK4A^-C72A expression ([Fig. 6](#fig6){ref-type="fig"}B, top panel) in otherwise p16^INK4A^ deficient COLO829 melanoma cells. CCNE2 transcription was partially restored upon diamide treatment, but not in the cells expressing the p16^INK4A^-C72A redox-insensitive variant. The induction of CCNE2 by diamide in the absence of doxycycline in the p16^INK4A^ WT cell line is likely due to the fact that the inducible system is somewhat leaky. Although we did find evidence that CDK4/6 is indeed reactivated upon oxidation of p16^INK4A^, and that this partially relieves E2F1 repression, we did not find evidence of perturbation of the S-phase checkpoint in cell-cycle analysis experiments using flow cytometry and video time-lapse microscopy (data not shown). This might be explained by the notion that substantial amounts of monomeric p16^INK4A^ persist under conditions where we find aggregated p16^INK4A^ in the insoluble pellet fraction of our lysates. The observed reactivation of CDK4/6 might therefore not be strong enough for full re-entry of the cell cycle under the tested conditions, but we cannot exclude that this might occur in other situations. Furthermore, treatment with oxidizing agents also affects the cell cycle through several other pathways, possibly obscuring p16^INK4A^ oxidation dependent effects.

3.8. Evolutionary analysis of the redox sensitive cysteine in p16^INK4A^ {#sec3.8}
------------------------------------------------------------------------

Aggregation and inactivation of a tumor suppressor protein may seem a maladaptive response to oxidizing conditions, although we cannot exclude that it may support another currently unknown biological function. Conservation of evolutionarily-acquired cysteines at the surface of proteins can be indicative for a role in redox signaling, whereas the loss of acquired cysteines may indicate the cysteine hampers protein function \[[@bib11],[@bib39]\]. We therefore investigated to what extent p16^INK4A^ Cys72 is conserved throughout evolution. The genes encoding p16^INK4A^ (*CDKN2A)* and p15^INK4B^ *(CDKN2B)* are the product of a gene duplication that occurred somewhere in evolution around the time that the mammalian branch of the evolutionary tree was formed \[[@bib40]\] (see [Fig. S12A](#appsec1){ref-type="sec"} for reference). Strikingly, Cys72 in the human protein is not conserved in any of the protein sequences of the *CDKN2* orthologues in fish, birds, reptiles and amphibians. Yet, this cysteine is present in both p16^INK4A^ and p15^INK4B^ in almost all mammalian species for which sequence information is available in the ENSEMBL database \[[@bib29]\], suggesting that acquisition of this cysteine occurred just before or coincided with the gene duplication of the ancestral *CDKN2* gene ([Fig. 7](#fig7){ref-type="fig"}A and B). Further investigation of the protein sequences of the p16^INK4A^ and p15^INK4B^ orthologues revealed that the cysteine homologous to the human p16^INK4A^-Cys72 was substituted later in evolution in several branches of mammalian species including some primates, rodentia and perissodactyla (see [Fig. 7](#fig7){ref-type="fig"}A and B and [Fig. S12B](#appsec1){ref-type="sec"}). The latter could indicate that redox regulation of the acquired cysteine homologous to human p16^INK4A^Cys72 is not absolutely required for a p16^INK4A^ function and that Cys72 might be slightly deleterious and displays a weak purifying selection.Fig. 7**Evolutionary analysis of p16**^**INK4A**^**and its paralogue p15**^**INK4B**^**.(A)** Conservation of Cys72 in human p16^INK4A^ and **(B)** Cys74 in its paralogue p15^INK4B^ throughout vertebrate evolution. Note that ENSEMBL \[[@bib29]\] assigns some non-mammalian orthologues to either p16^INK4A^ or p15^INK4B^ whereas gene duplication to yield these paralogues did not take place until mammalian species had branched off \[[@bib40]\]. Sequences are named by ENSEMBL ID \[[@bib29]\]. The human orthologues are indicated with \* and in bold. Cysteines conserved at the position homologous to human p16^INK4A^Cys72 are indicated on yellow background, other cysteines are in yellow text. The darker the purple shading the more conserved the amino acids. Note that several distant branches of mammals have lost the cysteine homologous to human p16^INK4A^Cys72. See [Fig. S12](#appsec1){ref-type="sec"} for a schematic tree of vertebrate and mammalian evolution for reference. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 7

4. Discussion {#sec4}
=============

Amyloid fibrils are structures that can be formed by a wide variety of protein sequences \[[@bib41]\]. These fibrils share common features, including an unbranched fibrillar morphology and a cross-β sheet core structure. Amyloids were previously thought to be largely disease-related, especially involved in neurodegenerative diseases, but there are increasing numbers of amyloid fibrils discovered that have a physiological function. Several mammalian examples have been reported in recent years, including the melanosome protein pMeL, amyloids involved in hormone storage, and the RIPK proteins, whose fibril formation appears to trigger necroptotic signaling pathways \[[@bib42], [@bib43], [@bib44], [@bib45]\]. In this work we show that p16^INK4A^ can form fibrils under physiological conditions and in cell-based models, and that the formation is triggered by oxidation of the single cysteine residue and homodimerization. We presented evidence that p16^INK4A^ can form aggregates that have the typical features of amyloid fibrils, including binding of diagnostic dyes, presence of cross-β sheet structure, and typical dimensions found in EM. The critical dependence of a disulfide cross-linked dimer as a subunit has not been observed so far and highlights the role of the cellular redox state as an important regulator of fibril formation.

The role of cysteine chemistry in amyloid formation has been discussed in detail previously \[[@bib46]\]. Most commonly, disulfide bonds are found to stabilize a soluble, usually monomeric, form of the protein, preventing its un- or misfolding and aggregation. In many cases, blocking of disulfide bond formation by mutagenesis or chemistry generates proteins that are more prone to amyloid formation, such as has been demonstrated for lysozyme \[[@bib47]\], SOD1 \[[@bib48],[@bib49]\], insulin \[[@bib50]\] and prion protein \[[@bib51],[@bib52]\]. In contrast, oxidation of the single cysteine of p16^INK4A^ is important for the transition of the monomeric protein to form amyloid fibrils, and modification of the cysteine by mutagenesis or S-glutathionylation prevents its amyloid formation. Proteins in which disulfide bonds have been postulated to be involved in stabilization of amyloid fibrils include the prion protein and RIPK fibrils, however disulfide bond formation itself is not required for conversion to amyloid in either of these cases \[[@bib51], [@bib52], [@bib53]\].

Several properties of p16^INK4A^ fibrils fit with those expected for functional amyloids, including their rapid formation (instead, disease-related amyloids can take days to form fibrils) \[[@bib54],[@bib55]\], and their lack of clear polymorphism (no evidence of peak doubling in the solid-state NMR spectrum) \[[@bib56],[@bib57]\]. We have shown that p16^INK4A^ fibrils can be formed *in vitro* under relatively mildly oxidizing conditions at physiological pH. In contrast to many other amyloid-forming proteins, p16^INK4A^ does not require harsh treatments, such as extreme pH, high temperatures, high pressure or organic solvents, that are frequently used to destabilize folded proteins in order to convert them to amyloid fibrils in a practical time scale. One striking difference in the properties of p16^INK4A^ amyloid fibrils, compared to classical disease-linked amyloids like amyloid-β and α-synuclein, is the apparent reversibility of the fibrillar state. Typical amyloids are highly stable and are not disaggregated by SDS buffers and do not run into SDS-PAGE gels \[[@bib41],[@bib58],[@bib59]\]. Our results show that SDS is able to disaggregate p16^INK4A^ fibrils into dimers, and that reducing-agent treatment further returns p16^INK4A^ to a monomeric state. This was shown for both recombinantly-produced p16^INK4A^ amyloid *in vitro*, as well as p16^INK4A^ amyloid formed in a cellular model. Furthermore, we find that p16^INK4A^ amyloids are transiently formed and do not persist in the cellular environment as judged by the filter trap assay. Clearance of the amyloids in cells could in principle proceed through degradation or disaggregation into monomers. There does not seem to be a clear increase of the monomeric form upon disappearance of the aggregates, which could suggest that the aggregates are being degraded rather than disaggregated. A recent study showed that p16^INK4A^ also forms aggregates upon inhibition of autophagy \[[@bib60]\], which is in line with this notion. The observation that p16^INK4A^ amyloids are reversible and can be cleared from cells potentially adds to an emerging pattern of lability of amyloid fibrils that have functional roles in the cell. For example, RIPK1/3, and the phase-separating proteins FUS and hnRNPA2 are all reported to form functional amyloid fibrils, and are apparently SDS soluble \[[@bib50],[@bib53]\]. This may be a hallmark for functional fibrils, which must be regulated and removed when the function is no longer needed. In contrast, highly stable, persistent aggregates may have toxic properties, such as in the case of Tau or TDP-43 aggregates, which are pathogenically related to various neurodegenerative diseases \[[@bib61],[@bib62]\].

It is now generally accepted that the cellular redox environment contributes to various signaling pathways and that H~2~O~2~ can act as a secondary messenger molecule \[[@bib9]\]. Cysteine residues are frequently found to be modified in large-scale analysis of the cysteinome and thousands of proteins are affected by redox regulation \[[@bib63],[@bib64]\]. Redox potentials vary widely between cell types and specific compartments, ranging from −374 mV for the strongly reducing NADPH/NADP^+^ redox couple in the liver cytosol to −180 mV from the GSH/GSSG couple in the oxidizing endoplasmic reticulum of B-cells \[[@bib18]\]. In addition, the average redox potential varies greatly between cell cycle stages \[[@bib65]\]. The redox potential of −198 mV that we found for the oxidation of C72 of p16^INK4A^ is well within the physiological range. One difference between *in vitro* and cell culture oxidation of p16^INK4A^ is that *in vitro* p16^INK4A^ could be stably GSH-ylated whereas in cell cultures we only observed the disulfide-bonded homodimer. This might seem surprising, because there is ample GSH available in the cell and addition of micromolar ranges of diamide will likely react to form GSSG. Therefore, it may be unlikely that in cells diamide and H~2~O~2~ oxidize p16^INK4A^ directly, but rather that its oxidation is the result of a redox relay or disulfide exchange mechanism, as has been proposed for other redox-sensitive proteins \[[@bib66]\]. However, we cannot exclude that transient GSH-ylation of p16^INK4A^ occurs in cells. Of note, tumor cells have been frequently reported to exhibit a more oxidizing milieu \[[@bib67]\]. This could mean that p16^INK4A^ would be more often in the dimerized and aggregated state, which could contribute to reactivation of CDK4/6 in tumors that express p16^INK4A^. One might argue that p16^INK4A^ inactivation by oxidizing conditions would be an inadequate response, that would be lost through evolutionary pressure. Evolutionary analysis indeed shows that the cysteine homologous to human p16^INK4A^-Cys72 was acquired recently: near or coinciding with the appearance of mammals and was then substituted again multiple times in several branches of mammalian evolution. However, this analysis would have to be further extended to be able to reject a potential beneficial biological role for p16^INK4A^ amyloid formation, for instance to temporarily reactivate CDK4/6 in cells with high p16^INK4A^ levels. Whether and how this indeed could also contribute to tumor progression remains to be established. Our pull-down experiments indicate that oxidation of p16^INK4A^ leads to loss of its inhibitory activity towards CDK4/6 but that oxidized p16^INK4A^ and CDK4/6 still interact. We speculate that the CDK4/6 interaction that we observe is of a different nature, which could underlie loss of inhibition of CDK4/6 upon oxidation of p16^INK4A^. Amyloid formation-dependent inactivation of tumor suppressor proteins has been described before for p53 and also in this case amyloid formation was reversible \[[@bib68]\].

Taken together, the presented work shows that redox signaling can trigger the formation of amyloid fibrils from an otherwise alpha-helical protein. Conversion of a protein from a soluble, monomeric to an insoluble, β-amyloid fibrillar phase dependent on the cellular redox state has not been reported before. This could pose a more general mechanism in amyloid formation, as was recently shown for redox-dependent liquid-liquid phase-separation \[[@bib69]\]. It also adds to the repertoire of structural alterations known to occur in response to redox signaling.
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